Paper35154604
Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches.
Olfatifar M and 12 others. Gastroenterol Hepatol Bed Bench, 2021. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches. Papers, record 35154604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35154604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26284562 | Biologic agents for IBD: practical insights. | Nat Rev Gastroenterol Hepatol | 2015 | https://conductscience.org/library/papers/26284562 | PubMed |
| 2 | 12519547 | Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12519547 | PubMed |
| 3 | 8246705 | Markov models in medical decision making: a practical guide. | Med Decis Making | 1993 | https://conductscience.org/library/papers/8246705 | PubMed |
| 4 | 28591172 | Multi-state modelling of heart failure care path: A population-based investigation from Italy. | PLoS One | 2017 | https://conductscience.org/library/papers/28591172 | PubMed |
| 5 | 16481629 | European evidence based consensus on the diagnosis and management of Crohn's disease: current management. | Gut | 2006 | https://conductscience.org/library/papers/16481629 | PubMed |
| 6 | 29359275 | The Natural History of IBD: Lessons Learned. | Curr Treat Options Gastroenterol | 2018 | https://conductscience.org/library/papers/29359275 | PubMed |
| 7 | 18562394 | Multi-state models for the analysis of time-to-event data. | Stat Methods Med Res | 2009 | https://conductscience.org/library/papers/18562394 | PubMed |
| 8 | 21765868 | Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. | Ther Adv Gastroenterol | 2011 | https://conductscience.org/library/papers/21765868 | PubMed |
| 9 | 21575882 | Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. | J Crohns Colitis | 2011 | https://conductscience.org/library/papers/21575882 | PubMed |
| 10 | 10889150 | Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10889150 | PubMed |
| 11 | 31448080 | Biologic therapies for Crohn's disease: optimising the old and maximising the new. | F1000Res | 2019 | https://conductscience.org/library/papers/31448080 | PubMed |
| 12 | 29610508 | ACG Clinical Guideline: Management of Crohn's Disease in Adults. | Am J Gastroenterol | 2018 | https://conductscience.org/library/papers/29610508 | PubMed |
| 13 | 17258717 | Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. | Gastroenterology | 2007 | https://conductscience.org/library/papers/17258717 | PubMed |
| 14 | 27231514 | Inflammatory bowel disease surgery in the biologic era. | World J Gastrointest Surg | 2016 | https://conductscience.org/library/papers/27231514 | PubMed |
| 15 | 20393175 | Infliximab, azathioprine, or combination therapy for Crohn's disease. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20393175 | PubMed |
| 16 | 2670519 | Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy. | Drugs | 1989 | https://conductscience.org/library/papers/2670519 | PubMed |
| 17 | 30881899 | Personalising medicine in inflammatory bowel disease-current and future perspectives. | Transl Pediatr | 2019 | https://conductscience.org/library/papers/30881899 | PubMed |
| 18 | 29925913 | No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials. | Am J Gastroenterol | 2018 | https://conductscience.org/library/papers/29925913 | PubMed |
| 19 | 26589956 | Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. | J Crohns Colitis | 2016 | https://conductscience.org/library/papers/26589956 | PubMed |
| 20 | 26811644 | How to predict clinical relapse in inflammatory bowel disease patients. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26811644 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35154604
GET https://conductscience.org/api/papers/v1/35154604/references?page=2